Bordetella species. In: Mandell, GL, Bennett, JE, Dolin, R. Principles and Practice of Infectious Diseases, 6th edn. Philadelphia, PA: Churchill Livingstone, 2004, pp. 2701–2708.
Crowcroft, NS, Pebody, RG. Recent developments in pertussis. Lancet
2006; 367: 1926–1936.
Hewlett, EL, Edwards, KM. Clinical practice: pertussis – not just for kids. New England Journal of Medicine
2005; 352: 1215–1222.
Cherry, JD. Historical review of pertussis and the classical vaccine. Journal of Infectious Diseases
1996; 174: S259–S263.
Wirsing von Konig, CH, et al.
Pertussis of adults and infants. Lancet Infectious Diseases
2002; 2: 744–750.
Tan, T, Trindade, E, Skowronski, D. Epidemiology of pertussis. Pediatric Infectious Diseases Journal
2005; 24 (5 Suppl.): S10–S18.
Skowronski, DM, et al.
The changing age and seasonal profile of pertussis in Canada. Journal of Infectious Diseases
2002; 185: 1448–1453.
Wirsing von König, CH, et al.
Pertussis in adults: frequency of transmission after household exposure. Lancet
1995; 346: 1326–1329.
National Institute of Public Health-National Institute of Hygiene. Annual reports ‘Vaccinations in Poland’ (www.pzh.gov.pl/epimeld). Accessed 23 January 2013.
Gzyl, A, et al.
Pertussis in Poland. International Journal of Epidemiology
2004; 33: 358–365.
Rastawicki, W, et al.
Reliability of the cut-off value in the routine serodiagnosis of pertussis performed by the commercial ELISA assays [in Polish]. Medycyna Dowiadczalna Mikrobiologia
2011; 63: 73–80.
Kösters, K, Riffelmann, M, Wirsing von König, CH. Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples. Journal of Medical Microbiology
2001; 50: 436–440.
StataCorp. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP, 2011.
Lohr, S. Sampling: Design and Analysis
, 2nd edn. Boston, MA: Brooks/Cole, Cengage Learning, 2009, pp. 344.
Schmitt-Grohé, S, et al.
Pertussis in German adults. Clinical Infectious Diseases
1995; 21: 860–866.
Nennig, ME, et al.
Prevalence and incidence of adult pertussis in an urban population. Journal of American Medical Association
1996; 275: 1672–1674.
Miller, E, et al.
Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham. Communicable Disease and Public Health
2000; 3: 132–134.
Strebel, P, et al.
Population-based incidence of pertussis in adolescents and adults, Minnesota, 1995–1996. Journal of Infectious Diseases
2001; 183: 1353–1359.
Gilberg, S, et al.
Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. Journal of Infectious Diseases
2002; 186: 415–418.
Lasserre, A, et al.
Pertussis incidence in adolescents and adults surveyed in general practices in the Paris area, France, May 2008 to March 2009. Eurosurveillance
2011; 16: pii = 19783.
Pebody, RG, et al.
The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiology and Infection
2005; 133: 159–171.
Kretzschmar, M, Teunis, PF, Pebody, RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Medicine
2010; 7: e1000291.
Mooi, FR, van der Maas, NA, De Melker, HE. Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin. Epidemiology and Infection. Published online:
André, P, et al.
Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. Journal of Clinical Microbiology
2008; 46: 1672–1677.
Guiso, N, et al.
What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. European Journal of Clinical Microbiology and Infectious Diseases
2011; 30: 307–312.
Riffelmann, M, et al.
Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis
. Journal of Clinical Microbiology
2010; 48: 4459–4463.
He, Q, et al.
High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis in European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance. Eurosurveillance
2012; 17: pii = 20 239.